Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics
International Journal of Molecular Sciences · 17.02.2023 · 24 (4) · 4103
DOI: 10.3390/ijms24044103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.02.2023. Verfasst von Nicolas Fage und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Intensive Care, University Hospital of Angers, 49100 Angers, France. Hauptthemen laut MEDLINE: Shock, Hemorrhagic, Shock, Septic. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
During hemorrhagic shock, blood loss causes a fall in blood pressure, decreases cardiac output, and, consequently, O2 transport. The current guidelines recommend the administration of vasopressors in addition to fluids to maintain arterial pressure when life-threatening hypotension occurs in order to prevent the risk of organ failure, especially acute kidney injury. However, different vasopressors exert variable effects on the kidney, depending on the nature and dose of the substance chosen as follows: Norepinephrine increases mean arterial pressure both via its α-1-mediated vasoconstriction leading to increased systemic vascular resistance and its β1-related increase in cardiac output. Vasopressin, through activation of V1-a receptors, induces vasoconstriction, thus increasing mean arterial pressure. In addition, these vasopressors have the following different effects on renal hemodynamics: Norepinephrine constricts both the afferent and efferent arterioles, whereas vasopressin exerts its vasoconstrictor properties mainly on the efferent arteriole. Therefore, this narrative review discusses the current knowledge of the renal hemodynamic effects of norepinephrine and vasopressin during hemorrhagic shock.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Intensive Care, University Hospital of Angers, 49100 Angers, France.
- MITOVASC Laboratory, UMR INSERM (French National Institute of Health and Medical Research), 1083-CNRS 6015, University of Angers, 49933 Angers, France.
- Institut Für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum, Helmholtzstrasse 8-1, 89081 Ulm, Germany.
- Department of Intensive Care (Service de Médecine Intensive-Réanimation), Nouvel Hôpital Civil, University Hospital of Strasbourg, 67000 Strasbourg, France.
- INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS (Fédération de Médecine Translationnelle de Strasbourg), University of Strasbourg, 67000 Strasbourg, Fra…
ORCID-Profile: Nicolas Fage
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Fage, N., Asfar, P., Radermacher, P., & Demiselle, J. (2023). Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics. International Journal of Molecular Sciences, 24(4), 4103. https://doi.org/10.3390/ijms24044103
Vancouver
Fage N, Asfar P, Radermacher P, Demiselle J. Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics. International Journal of Molecular Sciences. 2023;24(4):4103. doi:10.3390/ijms24044103
BibTeX
@article{Fage2023,
author = {Fage, Nicolas and Asfar, Pierre and Radermacher, Peter and Demiselle, Julien},
title = {Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4103},
doi = {10.3390/ijms24044103}
}
EUVIMED